TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Torque Therapeutics Stock

Torque Therapeutics Stock

torquetx.comHealthcareFounded: 2015Funding to Date: $84.27MM

Developer of an online platform intended to provide immunotherapy services. The company is focused on the specific modulation of immune cell subsets based on novel platform technologies to address intractable cancers, particularly solid tumors, enabling doctors to get new cell therapy cures for cancer.

Buy or sell Torque Therapeutics stockLearn more about Torque Therapeutics IPO
Register for Details

For more details on financing and valuation for Torque Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Torque Therapeutics.

Register Today

Team

Management Team

Bart Henderson
Co-Founder, President & Board Member
Thomas Andresen Ph.D
Co-Founder and Chief Scientific Officer
Stephen Hodi MD
Scientific Advisory Board Member
Doug Cole MD
Chairman
John Cox
Chief Executive Officer & Board Member
Douglas Jones
Director
Darrell Irvine Ph.D
Co-Founder
Sok Cheng Soh
Chief Financial Officer
Jennifer Camacho JD
Chief Legal Officer
Becker Hewes MD
Chief Medical Officer

Board Members

Doug Cole MD
John Dineen
Douglas Lauffenburger Ph.D
John Cox
Bart Henderson
John Hohneker MD

Other companies like Torque Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Business Wire 10/02/2019
Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer
Torque Therapeutics, a clinical stage, product-platform company developing proprietary, first-in-class Deep Primed™ adoptive cell transfer therapeutic
Xconomy 11/14/2017
Xconomy: With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer
Genetic engineering a patient’s own immune cells to make them better cancer fighters is the latest tool in oncology, following FDA approvals of two such

Trending Companies

Frequently Asked Questions